Bone marker CTX-1 as an indicator of osteoporosis treatment initiation and adherence in clinical practice

被引：0
|
作者：
Senay, Andrea [1 ]
Perreault, Sylvie [1 ]
Delisle, Josee [2 ]
Morin, Suzanne N. [3 ]
Banica, Andreea [2 ]
Laflamme, G. Yves [2 ]
Leduc, Stephane [2 ]
MacThiong, Jean-Marc [2 ]
Ranger, Pierre [2 ]
Rouleau, Dominique [2 ]
Fernandes, Julio C. [2 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
[2] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[3] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
887
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [21] Clinical lesson - Osteoporosis in clinical practice - investigation and treatment
    Davey, DA
    SOUTH AFRICAN MEDICAL JOURNAL, 1998, 88 (05): : 586 - +
  • [22] Osteoporosis in clinical practice - Bone densitometry and fracture risk
    Davey, DA
    SOUTH AFRICAN MEDICAL JOURNAL, 1998, 88 (11): : 1419 - 1423
  • [23] Multi-Modal Intervention for Improving Osteoporosis Treatment Initiation and Adherence.
    Outman, Ryan
    Muntner, Paul
    Bradlyn, Andrew
    Curtis, Jeffrey
    Cromwell, Lee
    Roblin, Douglas Wilmot
    Tolsma, Dennis
    Walker-Williams, Doraina
    Saag, Kenneth
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S364 - S364
  • [24] Diversification of bone mineral density and TRACP-5b,CTX-1,BAP in postmenopausal diabetic women and related factors analyzed
    Li, Yukuin
    Wang, Yan
    Wu, Fan
    Li, Baoxin
    Haung, Yi
    Liu, Yan
    BONE, 2008, 43 : S48 - S49
  • [25] Bone Density Testing to Monitor Osteoporosis Therapy in Clinical Practice
    Lewiecki, E. Michael
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (07) : 749 - 750
  • [26] The pharmacological treatment of osteoporosis in clinical practice ("TOP study")
    Rossini, M
    Bianchi, G
    Di Munno, O
    Giannini, S
    Minisola, S
    Sinigaglia, L
    Adami, S
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S86 - S86
  • [27] Development of clinical practice guidelines for prevention and treatment of osteoporosis
    Johnston, CC
    CALCIFIED TISSUE INTERNATIONAL, 1996, 59 : S30 - S33
  • [28] POOR ADHERENCE TO ANTI-OSTEOPOROSIS TREATMENT: DETERMINANTS, RECOMMENDATIONS FOR PRACTICE AND FOR RESEARCH
    Hiligsmann, M.
    Vrijens, B.
    Abrahamsen, B.
    Biver, Emmanuel
    Brandi, Maria Luisa
    Cooper, Cyrus
    Cornelissen, Dennis
    Cortet, Bernard
    Dennison, Elaine
    Diez-Perez, Adolfo
    Gasparik, Andrea
    Grosso, Alda
    Hadji, Peyman
    Halbout, Philippe
    Hiligsmann, Mickael
    Kanis, John
    Kaufman, Jean-Marc
    Maggi, Stefania
    Reginster, Jean-Yves
    Rizzoli, Rene
    Thomas, Thierry
    Tuzun, Sansin
    Al-Daghri, Nasser
    Bruyere, Olivier
    Burlet, Nansa
    Laslop, Andrea
    Vlaskovska, Mila
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S193 - S193
  • [29] Interleukin-6 May Not Affect Bone Resorption Marker CTX or Bone Formation Marker P1NP in Humans
    Lehrskov, Louise L.
    Kjeldsen, Sasha
    Lyngbaek, Mark P.
    Chirstensen, Regitse Hojgaard
    Wedell-Neergaard, Anne-Sophie
    Soderlund, Line
    Jorgensen, Niklas Rye
    Krogh-Madsen, Rikke
    Albrechtsen, Nicolai J. Wewer
    Ellingsgaard, Helga
    JOURNAL OF THE ENDOCRINE SOCIETY, 2020, 4 (09)
  • [30] Methods for evaluating psychiatric treatment adherence in clinical practice
    De las Cuevas, Carlos
    Sanz, Emilio J.
    REVISTA IBEROAMERICANA DE PSICOLOGIA Y SALUD, 2016, 7 (01): : 25 - 30
12345